A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
Clinical trial NCT03166631 · TERMINATED
Trial details
- NCT number
- NCT03166631
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-08
- Primary completion
- 2020-09-15
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.